Pierre Weigel

Title: Pierre Weigel: Innovator in Pharmaceutical Chemistry

Introduction

Pierre Weigel is a notable inventor based in Orvault, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of proliferative diseases.

Latest Patents

Weigel holds a patent for "Disulfonate stilbenes for use in the treatment of proliferative diseases." This patent includes compounds of a general formula where R and R' are independently selected from hydrogen and pharmaceutically acceptable cations. Additionally, R and R' are identical and selected from amide, carbamate, sulphonamide, azido, cyano, and halide. The patent also describes a pharmaceutical composition that may include another active ingredient, especially an antineoplastic agent. This composition is particularly relevant for the treatment of proliferative diseases, such as cancer.

Career Highlights

Throughout his career, Pierre Weigel has worked with esteemed institutions, including the University of Nantes and the Centre National de la Recherche Scientifique. His work has focused on innovative solutions in the pharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Weigel has collaborated with notable colleagues, including Fabrice Fleury and Alexandre Demeyer. These partnerships have fostered a collaborative environment that enhances research and development in his field.

Conclusion

Pierre Weigel's contributions to pharmaceutical chemistry, particularly through his patent on disulfonate stilbenes, highlight his role as an innovator in the treatment of proliferative diseases. His work continues to impact the medical field positively.